AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Varex Imaging Corp reported Q3 2025 revenue of $203mln, exceeding guidance. The industrial segment showed strength, with a 1% YoY increase in revenue. Non-GAAP gross margin was 34%, surpassing expectations. However, total revenue was down 3% YoY, with the medical segment declining by 4%. Operating expenses were unusually high, resulting in an operating loss of $81mln and a net loss of $89mln on a GAAP basis.
Varex Imaging Corp (Nasdaq: VREX) reported its unaudited financial results for the third quarter of fiscal year 2025, revealing a mixed performance. The company reported revenue of $203 million, exceeding the high end of its guidance. The industrial segment showed strength, with a 1% year-over-year (YoY) increase in revenue. However, the company's non-GAAP gross margin was 34%, surpassing expectations due to higher volume and favorable product sales mix [1].
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet